• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阻塞性肺疾病口腔、气道和肠道微生物群的改变:系统评价和荟萃分析。

The alterations of oral, airway and intestine microbiota in chronic obstructive pulmonary disease: a systematic review and meta-analysis.

机构信息

Department of Medicine, Qingdao University, Qingdao, China.

Department of Rehabilitation Medicine, Qingdao Municipal Hospital, University of Health and Rehabilitation Sciences, Qingdao, China.

出版信息

Front Immunol. 2024 May 8;15:1407439. doi: 10.3389/fimmu.2024.1407439. eCollection 2024.

DOI:10.3389/fimmu.2024.1407439
PMID:38779669
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11109405/
Abstract

BACKGROUND

Increasing evidence indicates the microbial ecology of chronic obstructive pulmonary disease (COPD) is intricately associated with the disease's status and severity, and distinct microbial ecological variations exist between COPD and healthy control (HC). This systematic review and meta-analysis aimed to summarize microbial diversity indices and taxa relative abundance of oral, airway, and intestine microbiota of different stages of COPD and HC to make comparisons.

METHODS

A comprehensive systematic literature search was conducted in PubMed, Embase, the Web of Science, and the Cochrane Library databases to identify relevant English articles on the oral, airway, and intestine microbiota in COPD published between 2003 and 8 May 2023. Information on microbial diversity indices and taxa relative abundance of oral, airway, and intestine microbiota was collected for comparison between different stages of COPD and HC.

RESULTS

A total of 20 studies were included in this review, involving a total of 337 HC participants, 511 COPD patients, and 154 AECOPD patients. We observed that no significant differences in alpha diversity between the participant groups, but beta diversity was significantly different in half of the included studies. Compared to HC, , , , and of oral microbiota in SCOPD were reduced at the genus level. Most studies supported that , , and were increased, but , , , , and were decreased at the genus level in the airway microbiota of SCOPD. However, the abundance of , and genera exhibited an increase, whereas and showed a decrease in the airway microbiota of AECOPD compared to HC. And of intestine microbiota in SCOPD was reduced at the genus level.

CONCLUSION

The majority of published research findings supported that COPD exhibited decreased alpha diversity compared to HC. However, our meta-analysis does not confirm it. In order to further investigate the characteristics and mechanisms of microbiome in the oral-airway- intestine axis of COPD patients, larger-scale and more rigorous studies are needed.

SYSTEMATIC REVIEW REGISTRATION

PROSPERO (https://www.crd.york.ac.uk/prospero/), identifier CRD42023418726.

摘要

背景

越来越多的证据表明,慢性阻塞性肺疾病(COPD)的微生物生态学与疾病的状态和严重程度密切相关,COPD 和健康对照组(HC)之间存在明显的微生物生态差异。本系统评价和荟萃分析旨在总结 COPD 不同阶段和 HC 的口腔、气道和肠道微生物群的微生物多样性指数和分类相对丰度,以进行比较。

方法

在 PubMed、Embase、Web of Science 和 Cochrane Library 数据库中进行全面的系统文献检索,以确定 2003 年至 2023 年 5 月 8 日期间发表的关于 COPD 口腔、气道和肠道微生物群的相关英文文章。收集口腔、气道和肠道微生物群的微生物多样性指数和分类相对丰度信息,以比较 COPD 不同阶段和 HC 之间的差异。

结果

本综述共纳入 20 项研究,共涉及 337 名 HC 参与者、511 名 COPD 患者和 154 名 AECOPD 患者。我们观察到,参与者组之间的 alpha 多样性没有显著差异,但在一半的纳入研究中,beta 多样性存在显著差异。与 HC 相比,SCOPD 患者的口腔微生物群在属水平上, 、 、 和 减少。大多数研究支持 SCOPD 患者的气道微生物群中 、 、 和 增加,但 、 、 、 和 减少。然而,AECOPD 患者的气道微生物群中 、 和 属的丰度增加,而 、 和 属的丰度减少。SCOPD 患者的肠道微生物群在属水平上减少 。

结论

大多数已发表的研究结果支持 COPD 患者的 alpha 多样性与 HC 相比降低。然而,我们的荟萃分析并不能证实这一点。为了进一步研究 COPD 患者口腔-气道-肠道轴微生物组的特征和机制,需要进行更大规模和更严格的研究。

系统评价注册

PROSPERO(https://www.crd.york.ac.uk/prospero/),标识符 CRD42023418726。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7b0/11109405/5489dc0ae9a3/fimmu-15-1407439-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7b0/11109405/49de0a5d8d8a/fimmu-15-1407439-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7b0/11109405/dcc6737bf8b8/fimmu-15-1407439-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7b0/11109405/464c4a9f32e8/fimmu-15-1407439-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7b0/11109405/eeca3cae53fe/fimmu-15-1407439-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7b0/11109405/5489dc0ae9a3/fimmu-15-1407439-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7b0/11109405/49de0a5d8d8a/fimmu-15-1407439-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7b0/11109405/dcc6737bf8b8/fimmu-15-1407439-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7b0/11109405/464c4a9f32e8/fimmu-15-1407439-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7b0/11109405/eeca3cae53fe/fimmu-15-1407439-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7b0/11109405/5489dc0ae9a3/fimmu-15-1407439-g005.jpg

相似文献

1
The alterations of oral, airway and intestine microbiota in chronic obstructive pulmonary disease: a systematic review and meta-analysis.慢性阻塞性肺疾病口腔、气道和肠道微生物群的改变:系统评价和荟萃分析。
Front Immunol. 2024 May 8;15:1407439. doi: 10.3389/fimmu.2024.1407439. eCollection 2024.
2
The Specific Alteration of Gut Microbiota in Diabetic Kidney Diseases-A Systematic Review and Meta-Analysis.糖尿病肾病中肠道微生物组的特定改变——系统评价和荟萃分析。
Front Immunol. 2022 Jun 17;13:908219. doi: 10.3389/fimmu.2022.908219. eCollection 2022.
3
Gut microbiota dysbiosis in ankylosing spondylitis: a systematic review and meta-analysis.肠内微生物失调与强直性脊柱炎:系统综述与荟萃分析。
Front Cell Infect Microbiol. 2024 Oct 1;14:1376525. doi: 10.3389/fcimb.2024.1376525. eCollection 2024.
4
Characteristics of the sputum microbiome in COPD exacerbations and correlations between clinical indices.COPD 加重期痰液微生物组特征及其与临床指标的相关性。
J Transl Med. 2022 Feb 5;20(1):76. doi: 10.1186/s12967-022-03278-x.
5
Variations in fecal microbial profiles of acute exacerbations and stable chronic obstructive pulmonary disease.急性加重期和稳定期慢性阻塞性肺疾病粪便微生物特征的变化。
Life Sci. 2021 Jan 15;265:118738. doi: 10.1016/j.lfs.2020.118738. Epub 2020 Nov 10.
6
Chronic obstructive pulmonary disease upper airway microbiome is associated with select clinical characteristics.慢性阻塞性肺疾病上呼吸道微生物群与某些临床特征有关。
PLoS One. 2019 Jul 23;14(7):e0219962. doi: 10.1371/journal.pone.0219962. eCollection 2019.
7
Promising Intestinal Microbiota Associated with Clinical Characteristics of COPD Through Integrated Bioinformatics Analysis.通过整合生物信息学分析发现与 COPD 临床特征相关的有前景的肠道微生物群。
Int J Chron Obstruct Pulmon Dis. 2024 Apr 5;19:873-886. doi: 10.2147/COPD.S436551. eCollection 2024.
8
Mechanismbased role of the intestinal microbiota in gestational diabetes mellitus: A systematic review and meta-analysis.肠道微生物群在妊娠糖尿病中的作用机制:系统评价和荟萃分析。
Front Immunol. 2023 Mar 3;13:1097853. doi: 10.3389/fimmu.2022.1097853. eCollection 2022.
9
Lung microbiome composition and bronchial epithelial gene expression in patients with COPD versus healthy individuals: a bacterial 16S rRNA gene sequencing and host transcriptomic analysis.慢性阻塞性肺疾病患者与健康个体的肺部微生物群组成及支气管上皮基因表达:细菌16S rRNA基因测序和宿主转录组分析
Lancet Microbe. 2021 Jul;2(7):e300-e310. doi: 10.1016/S2666-5247(21)00035-5. Epub 2021 Apr 23.
10
Long-Term Erythromycin Treatment Alters the Airway and Gut Microbiota: Data from Chronic Obstructive Pulmonary Disease Patients and Mice with Emphysema.长期红霉素治疗改变气道和肠道微生物群:来自慢性阻塞性肺疾病患者和肺气肿小鼠的数据。
Respiration. 2024;103(8):461-479. doi: 10.1159/000538911. Epub 2024 Apr 26.

引用本文的文献

1
Genetic evidence from Mendelian randomization strengthens the causality between oral microbiome and chronic obstructive pulmonary disease.孟德尔随机化的遗传证据强化了口腔微生物群与慢性阻塞性肺疾病之间的因果关系。
Medicine (Baltimore). 2025 Jul 25;104(30):e43347. doi: 10.1097/MD.0000000000043347.
2
Microbial dysbiosis in obstructive sleep apnea: a systematic review and meta-analysis.阻塞性睡眠呼吸暂停中的微生物群落失调:一项系统评价和荟萃分析。
Front Microbiol. 2025 May 15;16:1572637. doi: 10.3389/fmicb.2025.1572637. eCollection 2025.
3
Association between oral microbiome diversity and chronic obstructive pulmonary disease in the US population.

本文引用的文献

1
Gut and airway microbiota dysbiosis and their role in COVID-19 and long-COVID.肠道和气道微生物群落失调及其在 COVID-19 和长 COVID 中的作用。
Front Immunol. 2023 Mar 8;14:1080043. doi: 10.3389/fimmu.2023.1080043. eCollection 2023.
2
The Bidirectional Gut-Lung Axis in Chronic Obstructive Pulmonary Disease.双向肠-肺轴在慢性阻塞性肺疾病中的作用
Am J Respir Crit Care Med. 2023 May 1;207(9):1145-1160. doi: 10.1164/rccm.202206-1066TR.
3
Responsiveness to pulmonary rehabilitation in COPD is associated with changes in microbiota.
美国人群口腔微生物群多样性与慢性阻塞性肺疾病之间的关联。
J Transl Med. 2025 May 17;23(1):557. doi: 10.1186/s12967-025-06553-9.
4
Multiomics approach reveals the comprehensive interactions between nutrition and children's gut microbiota, and microbial and host metabolomes.多组学方法揭示了营养与儿童肠道微生物群以及微生物和宿主代谢组之间的全面相互作用。
Nutr J. 2025 Mar 29;24(1):50. doi: 10.1186/s12937-025-01116-6.
5
Prognostic risk prediction model for patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD): a systematic review and meta-analysis.慢性阻塞性肺疾病急性加重(AECOPD)患者预后风险预测模型:系统评价和荟萃分析。
Respir Res. 2024 Nov 14;25(1):410. doi: 10.1186/s12931-024-03033-4.
COPD 对肺康复的反应与微生物群的变化有关。
Respir Res. 2023 Jan 25;24(1):29. doi: 10.1186/s12931-023-02339-z.
4
Frequent exacerbators of chronic obstructive pulmonary disease have distinguishable sputum microbiome signatures during clinical stability.慢性阻塞性肺疾病的频繁急性加重者在临床稳定期有可区分的痰液微生物组特征。
Front Microbiol. 2022 Dec 1;13:1037037. doi: 10.3389/fmicb.2022.1037037. eCollection 2022.
5
A 16S rDNA sequencing-based analysis of airway microecology in patients with an acute exacerbation of chronic obstructive pulmonary disease: A cross-sectional study in Inner Mongolia, China.基于16S rDNA测序的慢性阻塞性肺疾病急性加重期患者气道微生态分析:中国内蒙古的一项横断面研究
Front Med (Lausanne). 2022 Oct 13;9:946238. doi: 10.3389/fmed.2022.946238. eCollection 2022.
6
The respiratory microbiota alpha-diversity in chronic lung diseases: first systematic review and meta-analysis.慢性肺部疾病的呼吸微生物群落α多样性:首次系统评价和荟萃分析。
Respir Res. 2022 Aug 23;23(1):214. doi: 10.1186/s12931-022-02132-4.
7
Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis.全球、区域和国家 2019 年慢性阻塞性肺疾病(COPD)的患病率、危险因素:系统评价和建模分析。
Lancet Respir Med. 2022 May;10(5):447-458. doi: 10.1016/S2213-2600(21)00511-7. Epub 2022 Mar 10.
8
Characteristics of the sputum microbiome in COPD exacerbations and correlations between clinical indices.COPD 加重期痰液微生物组特征及其与临床指标的相关性。
J Transl Med. 2022 Feb 5;20(1):76. doi: 10.1186/s12967-022-03278-x.
9
Saliva as a non-invasive specimen for COPD assessment.唾液作为 COPD 评估的非侵入性标本。
Respir Res. 2022 Jan 29;23(1):16. doi: 10.1186/s12931-022-01935-9.
10
Lung microbiome of stable and exacerbated COPD patients in Tshwane, South Africa.南非茨瓦内稳定期和加重期 COPD 患者的肺部微生物组。
Sci Rep. 2021 Oct 5;11(1):19758. doi: 10.1038/s41598-021-99127-w.